International Conference on GLP-1 Medicines and Metabolic Therapeutic Innovation

Important dates

1. 16 Dec

   Abstract / full paper deadline

   In 31 days

2. 17 Jan

   Conference

   Espoo, Finland

All deadlines are as published by the organizer. Check the official website for the time zone.

About this conference

Focus on the advancements in GLP-1 medications and their applications in tackling metabolic disorders will be at the heart of this conference. An open call for research papers, abstracts, and posters encourages scholars to share their findings on efficacy, safety, and innovative uses of GLP-1 therapeutics. Sessions will be arranged to promote discussions on clinical research, patient-centered approaches, and practical implications of therapy for metabolic diseases. This collaborative environment will foster networking and the sharing of best practices among academics, practitioners, and industry leaders. Detailed information regarding submission formats and deadlines will be provided to ensure participation from a diverse array of contributors. Engage in enlightening discourse that aims to set the stage for future breakthroughs in metabolic therapeutic strategies.

Call for papers

Abstracts are due by 16 December 2026. Submission details are on the official website.